KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Share-based Compensation: 2017-2025

Historic Share-based Compensation for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $64.5 million.

  • Twist Bioscience's Share-based Compensation rose 30.26% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.5 million, marking a year-over-year increase of 26.58%. This contributed to the annual value of $64.5 million for FY2025, which is 26.58% up from last year.
  • Per Twist Bioscience's latest filing, its Share-based Compensation stood at $64.5 million for FY2025, which was up 26.58% from $50.9 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Share-based Compensation ranged from a high of $79.7 million in FY2022 and a low of $30.3 million during FY2023.
  • For the 3-year period, Twist Bioscience's Share-based Compensation averaged around $48.6 million, with its median value being $50.9 million (2024).
  • As far as peak fluctuations go, Twist Bioscience's Share-based Compensation skyrocketed by 116.41% in 2021, and later plummeted by 61.99% in 2023.
  • Over the past 5 years, Twist Bioscience's Share-based Compensation (Yearly) stood at $37.0 million in 2021, then skyrocketed by 115.32% to $79.7 million in 2022, then tumbled by 61.99% to $30.3 million in 2023, then soared by 68.19% to $50.9 million in 2024, then grew by 26.58% to $64.5 million in 2025.